(S)-N-(2-oxoazetidin-3-yl)nonanamide

ID: ALA3770509

Chembl Id: CHEMBL3770509

PubChem CID: 81689844

Max Phase: Preclinical

Molecular Formula: C12H22N2O2

Molecular Weight: 226.32

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCC(=O)N[C@H]1CNC1=O

Standard InChI:  InChI=1S/C12H22N2O2/c1-2-3-4-5-6-7-8-11(15)14-10-9-13-12(10)16/h10H,2-9H2,1H3,(H,13,16)(H,14,15)/t10-/m0/s1

Standard InChI Key:  WIDAPGAIOCAZMY-JTQLQIEISA-N

Alternative Forms

Associated Targets(Human)

NAAA Tchem N-acylsphingosine-amidohydrolase (450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (6361 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 226.32Molecular Weight (Monoisotopic): 226.1681AlogP: 1.35#Rotatable Bonds: 8
Polar Surface Area: 58.20Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.87CX Basic pKa: CX LogP: 1.50CX LogD: 1.50
Aromatic Rings: Heavy Atoms: 16QED Weighted: 0.48Np Likeness Score: 0.15

References

1. Nuzzi A, Fiasella A, Ortega JA, Pagliuca C, Ponzano S, Pizzirani D, Bertozzi SM, Ottonello G, Tarozzo G, Reggiani A, Bandiera T, Bertozzi F, Piomelli D..  (2016)  Potent α-amino-β-lactam carbamic acid ester as NAAA inhibitors. Synthesis and structure-activity relationship (SAR) studies.,  111  [PMID:26866968] [10.1016/j.ejmech.2016.01.046]
2. Petracca R, Ponzano S, Bertozzi SM, Sasso O, Piomelli D, Bandiera T, Bertozzi F..  (2017)  Progress in the development of β-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives.,  126  [PMID:27915171] [10.1016/j.ejmech.2016.11.039]
3. Tuo W, Leleu-Chavain N, Spencer J, Sansook S, Millet R, Chavatte P..  (2017)  Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors.,  60  (1): [PMID:27766867] [10.1021/acs.jmedchem.6b00538]
4. Malamas MS, Farah SI, Lamani M, Pelekoudas DN, Perry NT, Rajarshi G, Miyabe CY, Chandrashekhar H, West J, Pavlopoulos S, Makriyannis A..  (2020)  Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors.,  28  (1): [PMID:31761726] [10.1016/j.bmc.2019.115195]
5. Malamas MS, Pavlopoulos S, Alapafuja SO, Farah SI, Zvonok A, Mohammad KA, West J, Perry NT, Pelekoudas DN, Rajarshi G, Shields C, Chandrashekhar H, Wood J, Makriyannis A..  (2021)  Design and Structure-Activity Relationships of Isothiocyanates as Potent and Selective N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibitors.,  64  (9.0): [PMID:33900772] [10.1021/acs.jmedchem.1c00076]

Source